scholarly article | Q13442814 |
P356 | DOI | 10.1212/01.WNL.0000229099.62706.A3 |
P698 | PubMed publication ID | 16864812 |
P50 | author | David Tanne | Q43183724 |
P2093 | author name string | Nira Koren-Morag | |
Uri Goldbourt | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cardiovascular disease | Q389735 |
P304 | page(s) | 224-228 | |
P577 | publication date | 2006-07-01 | |
P1433 | published in | Neurology | Q1161692 |
P1476 | title | Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. | |
P478 | volume | 67 |
Q37630057 | A Comparative Study of Neurological Complications in Chronic Kidney Disease with Special Reference to its Stages and Haemodialysis Status |
Q37626573 | A lower baseline glomerular filtration rate predicts high mortality and newly cerebrovascular accidents in acute ischemic stroke patients |
Q35865224 | A review of risk factors for stroke in patients with chronic kidney disease |
Q48437950 | Age dependent impact of estimated glomerular filtration rate on long-term survival after ischaemic stroke. |
Q24197614 | Antiplatelet agents for chronic kidney disease |
Q24200752 | Antiplatelet agents for chronic kidney disease |
Q24234115 | Antiplatelet agents for chronic kidney disease |
Q50995420 | Associations between biomarkers of renal function with cerebral microbleeds in hypertensive patients. |
Q33562172 | Carotid endarterectomy benefits patients with CKD and symptomatic high-grade stenosis |
Q47235063 | Cerebrovascular CO2 reactivity during isoflurane-nitrous oxide anesthesia in patients with chronic renal failure |
Q33280991 | Cerebrovascular effects of hemodialysis in chronic kidney disease |
Q91765149 | Chronic Kidney Disease Increases Cerebral Microbleeds in Mouse and Man |
Q56888925 | Chronic kidney disease and cause-specific hospitalisation: a matched cohort study using primary and secondary care patient data |
Q50574647 | Chronic kidney disease and cognitive impairment among the very old in China. |
Q34257447 | Chronic kidney disease itself is a causal risk factor for stroke beyond traditional cardiovascular risk factors: a nationwide cohort study in Taiwan |
Q50528127 | Chronic kidney disease, 24-h blood pressure and small vessel diseases are independently associated with cognitive impairment in lacunar infarct patients. |
Q42131922 | Cognitive function assessment in patients with end- stage renal disease in Nigeria: A single center experience |
Q38180990 | Cognitive impairment in chronic kidney disease: clinical findings, risk factors and consequences for patient care |
Q84153129 | Cognitive performance before and after kidney transplantation: a prospective controlled study of adequately dialyzed patients with end-stage renal disease |
Q89451315 | Crosstalk between the nervous system and the kidney |
Q34077863 | Decreased glomerular filtration rate is associated with mortality and cardiovascular events in patients with hypertension: a prospective study |
Q33589886 | Efficacy and safety of vitamin K-antagonists (VKA) for atrial fibrillation in non-dialysis dependent chronic kidney disease. |
Q44698833 | Epidemiology and risk factors for chronic kidney disease in patients with ischaemic stroke |
Q84978295 | Evidence-based practice guideline for the treatment of CKD |
Q33548607 | In-hospital major clinical outcomes in patients with chronic renal insufficiency presenting with acute coronary syndrome: data from a Registry of 8176 patients. |
Q46946189 | Ischaemic stroke--impact of renal dysfunction on in-hospital mortality |
Q86954179 | Ischemic stroke: the impact of renal dysfunction on 1-year mortality |
Q35025811 | Kidney function and cognitive performance and decline in older men. |
Q37245464 | Kidney function and estimated vascular risk in patients with primary dyslipidemia |
Q37368380 | Kidney function is associated with the rate of cognitive decline in the elderly. |
Q34168779 | Low glomerular filtration rate and risk of stroke: meta-analysis |
Q30252095 | Neurological complications in chronic kidney disease patients |
Q37590659 | Neurological complications of chronic kidney disease |
Q35044027 | Obesity and heart failure as a mediator of the cerebrorenal interaction |
Q58127362 | Plasma Cystathionine and Risk of Incident Stroke in Patients With Suspected Stable Angina Pectoris |
Q89537314 | Post-Stroke Depression and Estimated Glomerular Filtration Rate: A Prospective Stroke Cohort |
Q36475560 | Prevalence of clinical and subclinical thyroid disease in a peritoneal dialysis population |
Q35053592 | Proteinuria independently predicts unfavorable outcome of ischemic stroke patients receiving intravenous thrombolysis |
Q89075311 | Regional Cerebral Blood Flow in Children and Young Adults with Chronic Kidney Disease |
Q51542778 | Relationship Between Chronic Kidney Disease and White Matter Hyperintensities on Magnetic Resonance Imaging |
Q37838428 | Reno-cerebrovascular disease: linking the nephron and neuron |
Q48322311 | Risk reduction of long-term major adverse cardiovascular events after endoscopic thoracic sympathectomy in palmar hyperhidrosis. |
Q48508504 | Role of rivaroxaban in the management of atrial fibrillation: insights from clinical practice |
Q38008318 | Stroke and renal dysfunction: are we always conscious of this relationship? |
Q35153302 | Stroke in chronic kidney disease: prevention and management |
Q38821293 | The Cerebrovascular-Chronic Kidney Disease Connection: Perspectives and Mechanisms |
Q90420713 | The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders |
Q34559287 | The association between kidney disease and cardiovascular risk in a multiethnic cohort: findings from the Northern Manhattan Study (NOMAS). |
Q37245217 | Use of Selective Serotonin Reuptake Inhibitors and Risks of Stroke in Patients with Obsessive Compulsive Disorder: A Population-Based Study |